Johnson & Johnson Revenue by Segment

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Oct 2, 2022	Jul 3, 2022	Apr 3, 2022	Jan 2, 2022	Oct 3, 2021	Jul 4, 2021	Apr 4, 2021	Jan 3, 2021	Sep 27, 2020
Pharmaceutical	57.99B	57.28B	56.96B	56.35B	55.67B	54.91B	54.76B	54.20B				-	-		-	-	-	-	-
Pharmaceutical Growth	4.17%	4.31%	4.03%	3.97%	4.01%	3.39%	4.18%	1.09%				-	-		-	-	-	-	-
Medtech	32.64B	32.06B	31.86B	31.34B	30.91B	30.74B	30.40B	29.50B				-	-		-	-	-	-	-
Medtech Growth	5.60%	4.28%	4.79%	6.23%	7.22%	10.03%	10.84%	7.24%				-	-		-	-	-	-	-
Consumer Health	-	-	-	-	-	-	-	-	15.43B	15.22B	14.91B	-	-	14.82B	-	-	-	-	-
Consumer Health Growth	-	-	-	-	-	-	-	-	3.31%	2.41%	1.40%	-	-	5.44%	-	-	-	-	-

Revenue by Geography

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
United States	51.96B	50.99B	50.30B	49.61B	48.70B	49.58B	50.47B	50.41B
United States Growth	6.70%	2.85%	-0.34%	-1.58%	-3.77%	2.05%	4.66%	5.60%
Europe	20.33B	20.16B	20.21B	21.11B	20.92B	21.60B	22.77B	22.48B
Europe Growth	-2.81%	-6.67%	-11.23%	-6.10%	-12.23%	-9.87%	-7.28%	-8.71%
Asia Pacific and Africa	13.65B	13.50B	13.59B	14.16B	14.14B	15.17B	16.08B	16.50B
Asia Pacific and Africa Growth	-3.48%	-11.03%	-15.44%	-14.16%	-17.97%	-12.15%	-6.63%	-4.38%
Western Hemisphere Excluding US	4.68B	4.69B	4.71B	5.12B	5.12B	5.62B	6.02B	6.03B
Western Hemisphere Excluding US Growth	-8.61%	-16.65%	-21.64%	-15.07%	-19.94%	-8.82%	-0.38%	-0.71%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.